During the treatment period, routine CSF cytology examination was performed before each cycle of the chemotherapy, and fundus examinations and orbital MRI were performed every 4–8 weeks. Follow up every 3 months in the first 1–2 years, every 6 months in the 3–5 years, and once a year from the 6th year after treatment. During follow-up, we monitored patients for tumor recurrence though fundus examinations and orbital MRI. The prognosis of patients was indicated by the overall survival (OS). OS was calculated from the day of first admission to hospital to the time of the last follow-up or death.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.